Philips expands remote patient management with the introduction of Medical Tablet with advanced software
Royal Philips has launched the Philips Medical Tablet in North America, Europe, and Japan to facilitate remote patient monitoring during emergencies such as the COVID-19 pandemic. This portable device integrates with the IntelliVue XDS software, allowing clinicians to monitor multiple patients without being tied to central stations. The solution aims to improve workflows amidst increased patient volume and PPE shortages, enhancing safety for both patients and healthcare providers. With a focus on rapid deployment, the tablet is positioned to support hospitals adapting to the pandemic's challenges.
- Launch of Philips Medical Tablet designed for remote monitoring enhances patient care.
- Portable setup enables monitoring during emergencies, improving clinician efficiency.
- Integration with IntelliVue XDS software allows access to critical patient data remotely.
- Increased patient volume and PPE shortages could strain healthcare resources.
- Potential reliance on software and technology may introduce operational risks.
February 1, 2021
- New solution available in North America, Europe and Japan provides remote access to patient data to improve workflows to better manage increases in patient volume
- Offers full remote information access, can be easily deployed and enables a fully portable setup in emergency situations, including COVID-19
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced the Philips Medical Tablet, an end-to-end, easy-to-implement, portable monitoring kit designed to help clinicians remotely monitor larger patient populations during emergency situations, like the COVID-19 pandemic. The Medical Tablet integrates with Philips advanced IntelliVue XDS software to enable remote access of patient monitoring information, allowing clinicians to care for patients outside of the hospital setting. This solution is not tied to a central monitoring station and can therefore be operated through WiFi connection, making it easy to deploy and integrate into existing clinical structures and workflows. Additionally, with the Philips Medical Tablet, clinicians experience less exposure to infected patients, and can increase efficiency through less personal protective equipment (PPE) changing, ultimately improving patient and clinician safety.
The COVID-19 pandemic has created a variety of challenges across multiple care settings within the hospital, including higher than normal patient volume in emergency rooms, personnel shortages, reduced bed capacity and limited resources, particularly PPE. These challenges often lead to overcrowding, increased clinician workload, demand on resources and the added obstacle of trying to create separation between infected and non-infected patients to minimize the spread of disease.
In an effort to alleviate these challenges, hospitals are creating temporary care settings for COVID-19 patients outside of the hospital or in isolation wards, making remote and easily transferable tools essential in delivering consistent and quality care. During a time when both patient and clinician health and safety are paramount, the Philips Medical Tablet using XDS software can connect to multiple IntelliVue monitors in the same network, allowing clinicians to remotely monitor multiple patients to reduce contact as well as lessen bedside monitoring disturbances and interruptions.
“As clinicians work to navigate increased workloads, safety concerns, and transitions to remote care settings, they require solutions that map to these increasingly challenging circumstances,” said Peter Ziese, General Manager of Monitoring Analytics at Philips. “The Philips Medical Tablet with IntelliVue XDS software gives clinicians critical patient data like vital signs and clinical decision support applications right at their fingertips, empowering them to make informed care decisions no matter where they are.”
Outside of emergency-use situations, the Philips Medical Tablet with IntelliVue XDS software can be used as an extended screen, working as a companion to the IntelliVue monitor to display meaningful patient information through clinical decision support tools. It can also act as a clinical workspace, combining patient monitoring views and the hospital’s IT applications, allowing clinicians to simultaneously interact across multiple systems for enhanced patient care.
The Philips Medical Tablet, integrated with the IntelliVue XDS software joins a growing portfolio of solutions aimed at addressing the challenges and changes in patient care brought upon by COVID-19. As both patient safety concerns and clinician workloads rise, Philips’ remote patient monitoring services provide clinicians with the tools they need to help improve patient outcomes. Philips’ COVID-19-related solutions are designed for rapid deployment and scalability. To learn more about the Philips Medical Tablet please visit here.
For further information, please contact:
Anna Hogrebe
Philips Global Press Office
Tel.: +1 416 270 6757
E-mail: anna.hogrebe@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 19.5 billion and employs approximately 82,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachments
FAQ
What is the Philips Medical Tablet?
When was the Philips Medical Tablet launched?
How does the Philips Medical Tablet improve workflows?
What regions are receiving the Philips Medical Tablet?
What challenges does the Philips Medical Tablet address?
